BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 428428)

  • 41. [Synthesis and effect of affinity-labeled analogs and partial sequences of the bradykinin potentiating nonapeptide BPP9 alpha (teprotide)].
    Reissmann S; Paegelow I; Filatova MP; Krit NA; Arold H
    Pharmazie; 1985 May; 40(5):314-7. PubMed ID: 3898147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
    Kam YL; Ro JY; Kim HJ; Choo HY
    Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efffect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig.
    Mahmoudian M; Mojaverian N
    Acta Physiol Hung; 2001; 88(3-4):231-7. PubMed ID: 12162581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Potentiating effect of choline on the action of phenylacetate. I. Effect on the isolated ileum of the guinea pig].
    Ishida Y; Moritoki H
    Nihon Yakurigaku Zasshi; 1969 Jul; 65(4):303-8. PubMed ID: 4310400
    [No Abstract]   [Full Text] [Related]  

  • 45. The biphasic response of the isolated guinea-pig ileum by bradykinin.
    Hall DW; Bonta IL
    Eur J Pharmacol; 1973 Feb; 21(2):147-54. PubMed ID: 4348736
    [No Abstract]   [Full Text] [Related]  

  • 46. The bradykinin potentiating activity of two pentapeptides on various isolated smooth muscle preparations.
    Ufkes JG; Aarsen PN; Van Der Meer C
    Eur J Pharmacol; 1976 Nov; 40(1):137-44. PubMed ID: 1033071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
    Field JL; Butt SK; Morton IK; Hall JM
    Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kallikrein potentiation of angiotensin I-induced contraction on isolated mesenteric artery.
    Larsson-Backstrom C
    Adv Exp Med Biol; 1983; 156():445-55. PubMed ID: 6190376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro actions of somatostatin, D-Val1, D-Trp8-somatostatin and glucagon in rabbit jejunum and guinea-pig ileum.
    Cohen ML; Wiley KS; Yaden E; Slater IH
    J Pharmacol Exp Ther; 1979 Nov; 211(2):423-9. PubMed ID: 501572
    [No Abstract]   [Full Text] [Related]  

  • 50. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interaction between contractile action of low-molecular kininogen-like peptides on guinea pig ileum and trypsin].
    Kameyama T; Sasaki K; Suzuki K
    Yakugaku Zasshi; 1971 Jan; 91(1):1-5. PubMed ID: 5101910
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-spasmogenic effect of cyproheptadine on guinea-pig ileum.
    Reylon V; Siddiqui HH
    Indian J Physiol Pharmacol; 1983; 27(4):342-4. PubMed ID: 6678244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of bradykinin-induced contraction of isolated smooth muscle tissue preparations by oligopeptide thiobenzyl ester substrates for serine proteases.
    Fareed J; Kindel G; Walenga JM; Balis JU; Karczmar AG
    Adv Exp Med Biol; 1983; 156():597-605. PubMed ID: 6344575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of the bradykinin response by cysteine: mechanism of action.
    Potter DE; Walaszek EJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):338-49. PubMed ID: 4337940
    [No Abstract]   [Full Text] [Related]  

  • 55. Requirements for angiotensin tachyphylaxis in smooth muscles.
    Paiva TB; Miyamoto ME; Juliano L; Paiva AC
    J Pharmacol Exp Ther; 1977 Aug; 202(2):294-300. PubMed ID: 886468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The presence of a smooth muscle contracting and bradykinin potentiating factor in plasma.
    Louhija A; Sipilä R
    Biochem Pharmacol; 1972 Apr; 21(8):1151-8. PubMed ID: 5034199
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inhibition of angiotensin converting enzyme by (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid, SA 446].
    Horiuchi M; Terashima T; Fujimura K; Shimokawa K; Iso T
    Yakugaku Zasshi; 1984 Dec; 104(12):1257-62. PubMed ID: 6099853
    [No Abstract]   [Full Text] [Related]  

  • 58. [Contractile effects of synthetic bradykinin analogs on the isolated small intestine].
    Kameyama T; Sasaki K; Nabeshima J
    Nihon Heikatsukin Gakkai Zasshi; 1970 Mar; 6(1):33-9. PubMed ID: 5465030
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An attempt to differentiate the effects of angiotensin II, substance P and bradykinin on the field-stimulated guinea-pig vas deferens.
    Zetler G; Kampmann E
    Eur J Pharmacol; 1979 Jun; 56(1-2):21-9. PubMed ID: 467511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.